Stock Price Quote

SYNCOM FORMULATIONS (INDIA) LTD.

NSE : SYNCOMFBSE : 524470ISIN CODE : INE312C01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE7.470 (0 %)
PREV CLOSE ( ) 7.47
OPEN PRICE ( ) 7.51
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 361745
TODAY'S LOW / HIGH ( )7.35 7.61
52 WK LOW / HIGH ( )6.33 16.4
NSE7.45-0.05 (-0.67 %)
PREV CLOSE( ) 7.50
OPEN PRICE ( ) 7.55
BID PRICE (QTY) 7.45 (24)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 966753
TODAY'S LOW / HIGH( ) 7.30 7.60
52 WK LOW / HIGH ( )7.1 11.6
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 21-06 1988
Management Info
Kedarmal Bankda - Chairman Vijay Shankarlal Bankda - Managing Director
Registered Office

Address 7 Niraj Industrial Estate,Off Mahakali Caves Road,Andheri (E),
Mumbai,
Maharashtra-400093

Phone 022 30887744-54

Email sfil87@hotmail.com

Website www.sfil.in

Registrars Details
Ankit Consultancy Pvt Ltd
Plot No 60,Electronic Complex,Pardeshipura,Indore
Listing : BSE, NSE

NEWS

13Jan Syncom Formulations (India) submits re
With reference to the compliance of Regulation 76 of SEBI (Depositories..
21Dec Letter For Clarification For The Disc
We refer the email received from BSE Ltd. on dated 20th December, 2022 a..
20Sep Syncom Formulations (India) informs ab
Pursuant to the Regulation 30(2) read with Part A of Schedule III of the..
16Sep Syncom Formulations (India) completes
Syncom Formulations (India) has completed civil structure at company's e..
16Sep Syncom Formulations (India) inches up
Syncom Formulations (India) is currently trading at Rs. 9.07, up by 0.33..

Financials

in Millions
QTR Sep 22 ANNUAL 22
Net Profit35.98197.91
Gross Profit 53.69 261.77
Operating Profit 71.62314.56
Net Sales 544.912196.63

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE)
peergroup  4719.10 (15.19%)
M.Cap ( in Cr)7833.41
NGL Fine-Chem (BSE)
peergroup  1522.50 (2.66%)
M.Cap ( in Cr)940.60
Zydus Lifesciences (BSE)
peergroup  470.15 (8.33%)
M.Cap ( in Cr)47588.78
Mercury Laboratories (BSE)
peergroup  815.00 (3.82%)
M.Cap ( in Cr)97.80
AMI Organics (BSE)
peergroup  891.80 (2.82%)
M.Cap ( in Cr)3249.46

Shareholding Pattern

PROMOTERS 50.57%
NON-INSTITUTION 49.43%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
Motilal Oswal S&P B...0.06

About Syncom Formulations (India) Ltd.

Syncom Formulations (India) Ltd. was incorporated in the year 1988. Its today's share price is 7.47. Its current market capitalisation stands at Rs 702.18 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2196.63 Cr and Total Income of Rs.2316.56 Cr. The company's management includes Prachi Jain, Ruchi Jindal, Praveen Jindal, Vinod Kumar Kabra, Krishna Das Neema, Rinki Bankda, Vijay Shankarlal Bankda, Kedarmal Bankda.

It is listed on the BSE with a BSE Code of 524470 , NSE with an NSE Symbol of SYNCOMF and ISIN of INE312C01025. It's Registered office is at 7 Niraj Industrial Estate,Off Mahakali Caves Road,Andheri (E)Mumbai-400093, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Sanjay Mehta & Associates, SP Moondra & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)